Based on genome-wide DNA methylation and functional network analysis, selective CpG sites (NOS1AP, BID, and GABRB1) differentially methylated in smokers and COPD compared to non-smokers were validated by pyrosequencing. Here, BID is linked to chronic obstructive pulmonary disease.